These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 20525890)
41. Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide. Liao J; Wang X; Bi Y; Shen B; Shao K; Yang H; Lu Y; Zhang Z; Chen X; Liu H; Wang J; Chu Y; Xue L; Wang X; Liu G J Leukoc Biol; 2014 Nov; 96(5):675-84. PubMed ID: 24948701 [TBL] [Abstract][Full Text] [Related]
42. Myeloid cell population dynamics in healthy and tumor-bearing mice. Ueha S; Shand FH; Matsushima K Int Immunopharmacol; 2011 Jul; 11(7):783-8. PubMed ID: 21406269 [TBL] [Abstract][Full Text] [Related]
43. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas. Fujimura T; Ring S; Umansky V; Mahnke K; Enk AH J Invest Dermatol; 2012 Apr; 132(4):1239-46. PubMed ID: 22189788 [TBL] [Abstract][Full Text] [Related]
44. Myeloid-derived suppressor cells are key players in the resolution of inflammation during a model of acute infection. Arocena AR; Onofrio LI; Pellegrini AV; Carrera Silva AE; Paroli A; Cano RC; Aoki MP; Gea S Eur J Immunol; 2014 Jan; 44(1):184-94. PubMed ID: 24166778 [TBL] [Abstract][Full Text] [Related]
46. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. Wang L; Chang EW; Wong SC; Ong SM; Chong DQ; Ling KL J Immunol; 2013 Jan; 190(2):794-804. PubMed ID: 23248262 [TBL] [Abstract][Full Text] [Related]
47. Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation. Lee JM; Kim EK; Seo H; Jeon I; Chae MJ; Park YJ; Song B; Kim YS; Kim YJ; Ko HJ; Kang CY Eur J Immunol; 2014 Jun; 44(6):1672-84. PubMed ID: 24659444 [TBL] [Abstract][Full Text] [Related]
48. Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts. Maenhout SK; Van Lint S; Emeagi PU; Thielemans K; Aerts JL Int J Cancer; 2014 Mar; 134(5):1077-90. PubMed ID: 23983191 [TBL] [Abstract][Full Text] [Related]
49. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. Yi H; Guo C; Yu X; Zuo D; Wang XY J Immunol; 2012 Nov; 189(9):4295-304. PubMed ID: 23034169 [TBL] [Abstract][Full Text] [Related]
50. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors. Marttila-Ichihara F; Auvinen K; Elima K; Jalkanen S; Salmi M Cancer Res; 2009 Oct; 69(19):7875-83. PubMed ID: 19789345 [TBL] [Abstract][Full Text] [Related]
51. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses. Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713 [TBL] [Abstract][Full Text] [Related]
52. Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. Hegde VL; Nagarkatti PS; Nagarkatti M PLoS One; 2011 Apr; 6(4):e18281. PubMed ID: 21483776 [TBL] [Abstract][Full Text] [Related]
53. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis. Ye XZ; Yu SC; Bian XW J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706 [TBL] [Abstract][Full Text] [Related]
54. Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy. Tadmor T; Attias D; Polliack A Br J Haematol; 2011 Jun; 153(5):557-67. PubMed ID: 21477210 [TBL] [Abstract][Full Text] [Related]
55. Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells. Stewart TJ; Liewehr DJ; Steinberg SM; Greeneltch KM; Abrams SI J Immunol; 2009 Jul; 183(1):117-28. PubMed ID: 19542426 [TBL] [Abstract][Full Text] [Related]
56. [Inhibition of lipopolysaccharide-induced myeloid-derived suppressor cells in the proliferation of spleen T lymphocytes]. Zheng YN; Yu HP; Chen X; Deng HJ; Fan HZ; Gong YX; Liu JF Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(24):1702-5. PubMed ID: 22944163 [TBL] [Abstract][Full Text] [Related]
57. Transplantation of granulocytic myeloid-derived suppressor cells (G-MDSCs) could reduce colitis in experimental murine models. Su H; Cong X; Liu YL J Dig Dis; 2013 May; 14(5):251-8. PubMed ID: 23279711 [TBL] [Abstract][Full Text] [Related]
58. Amino acid metabolism related to immune tolerance by MDSCs. Yang B; Wang X; Ren X Int Rev Immunol; 2012 Jun; 31(3):177-83. PubMed ID: 22587019 [TBL] [Abstract][Full Text] [Related]
59. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro. Han EC; Lee J; Ryu SW; Choi C Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986 [TBL] [Abstract][Full Text] [Related]
60. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially. Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]